1 year return (CAGR)
37.70%
Tarsus Pharmaceuticals Inc Exchange (NASDAQ, USD)
TARS
79.95
-0.80 (-1.24%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
63.93%
5 year return (CAGR)
15.80%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.75B
Price/Sales
6.10
Ent value
2.79B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
21.68
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 62.70 |
| Daily high | 64.84 |
| Daily low | 59.00 |
| Daily Volume | 1.56M |
| All-time high | 90.78 |
| 1y analyst estimate | 94.86 |
| Beta | 0.51 |
| EPS (TTM) | -1.07 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 16 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TARS | S&P500 | |
| Current price drop from All-time high | -11.93% | -2.19% |
| Highest price drop | -77.67% | -56.47% |
| Date of highest drop | 6 May 2022 | 9 Mar 2009 |
| Avg drop from high | -40.75% | -10.68% |
| Avg time to new high | 32 days | 12 days |
| Max time to new high | 982 days | 1805 days |
News
